AEMD Aethlon Medical, Inc.
Healthcare$2.45+11.36%ClosedMarket Cap: $1.9M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
0.27
P/S
0.00
EV/EBITDA
0.44
DCF Value
$27.87
FCF Yield
-102706.2%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-219.4%
ROA
-143.0%
ROIC
-103.3%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q3 null | $0.00 | -Infinity% | $-2.1M | $-2.0M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-1.5M | $-1.5M | $— | — |
| Q1 null | $0.00 | -Infinity% | $-1.8M | $-1.8M | $— | — |
| Q4 null | $0.00 | -Infinity% | $-2.0M | $-6.3M | $— | — |
| FY null | $0.00 | NaN% | $-9.3M | $-13.4M | $— | — |
| Q3 null | $0.00 | NaN% | $-1.8M | $-1.8M | $— | — |
| Q2 null | $0.00 | NaN% | $-2.9M | $-2.8M | $— | — |
| Q1 null | $0.00 | NaN% | $-2.6M | $-2.6M | $— | — |
| Q4 null | $0.00 | NaN% | $-2.5M | $-2.4M | $— | — |
| FY null | $0.00 | NaN% | $-12.6M | $-12.2M | $— | — |
| Q3 2024 | $0.00 | NaN% | $-3.6M | $-3.5M | $-13.80 | — |
| Q2 2024 | $0.00 | NaN% | $-3.2M | $-3.0M | $-12.20 | — |